Last reviewed · How we verify
NCT06577610
The Impact of a Colonoscopy Monitoring Program on Endoscopists' Performance
NA trial testing Feedback from colonoscopy monitoring program in Adenoma Colon Polyp in 16 participants. Not yet recruiting.
1 October 2025
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 16 |
| Start date | 1 October 2024 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 October 2025 |
Drugs / interventions tested
- Feedback from colonoscopy monitoring program
Conditions studied
- Adenoma Colon Polyp — all drugs for Adenoma Colon Polyp →
- Sessile Serrated Adenoma — all drugs for Sessile Serrated Adenoma →
Sponsor
Seoul National University Hospital
Who can join
Eligibility, any sex, with Adenoma Colon Polyp or Sessile Serrated Adenoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if colonoscopy monitoring program works to adenoma detection rate in endoscopists. It will also learn about the impact on sessile serrated lesion detection rate, adenomas per colonoscopy, sessile serrated lesions per colonoscopy, advanced adenoma detection rate. The main questions it aims to answer are: Does colonoscopy monitoring program effect on adenoma detection rate in endoscopists? Participants will: Receive result of colonoscopy monitoring program or not every 3 months for 1 year
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06577610
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adenoma Colon Polyp
Currently open trials in the same condition.
- NCT06649123 — Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer · recruiting
- NCT06656312 — Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis · NA · recruiting
- NCT06406062 — Artificial Intelligence-assisted System in Colonoscopy · recruiting
- NCT07450612 — Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection · recruiting
- NCT06476145 — Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip So · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06577610 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06577610.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing